Document ID: chunk:federal_register_of_legislation:F2025L00049:schedule:10:p2
Version: federal_register_of_legislation:F2025L00049
Segment Type: schedule
Provision Reference: sch 10 (pt 2/4)
Character Range: 445319–448755

use:

       (a) is in accordance with:

          (i) an approval granted under paragraph 19(1)(b) of the Act, including any conditions specified in the notice of approval; and

          (ii) any conditions specified in the Therapeutic Goods Regulations 1990 for the purposes of subsection 19(1A) of the Act; and

          (iii) any conditions specified in the Therapeutic Goods Regulations 1990 for the purposes of subsection 19(4A) of the Act; or

       (b) is in accordance with the requirements of item 3 of Schedule 5A to the Therapeutic Goods Regulations 1990.
COAL TAR for cosmetic use other than in therapeutic goods.
CONIUM MACULATUM (coniine) for therapeutic use.
COTARNINE for therapeutic use.
CROTALARIA spp. for therapeutic use.
CROTON TIGLIUM for therapeutic use.
CYNOGLOSSUM spp. for therapeutic use.
DIBUTYL PHTHALATE for cosmetic use.
DICOPHANE (DDT) for therapeutic use.
DIETHYLENE GLYCOL for use in toothpastes or mouthwashes except in preparations containing 0.25% or less of diethylene glycol.
DIETHYLENE GLYCOL MONOMETHYL ETHER for cosmetic use.
DIETHYLHEXYL PHTHALATE for cosmetic use.
DIETHYLPHTHALATE in sunscreens, personal insect repellents or body lotion preparations for human use except in preparations containing 0.5% or less of diethylphthalate.
5,6‑DIHYDROXYINDOLINE for cosmetic use in preparations containing more than 2% of 5,6‑dihydroxyindoline.
DIIODOHYDROXYQUINOLINE (iodoquinol) for human internal use.
DIISOBUTYL PHTHALATE for cosmetic use.
1,3‑DIMETHYLAMYLAMINE (DMAA).
1,3‑DIMETHYLBUTYLAMINE (DMBA) except when separately specified in these schedules.
1‑(1,1‑DIMETHYLETHYL)‑2‑METHOXY‑4‑METHYL‑3,5‑DINITROBENZENE (musk ambrette).
1,5‑DIMETHYLHEXYLAMINE (DMHA) except when separately specified in these schedules.
DI(METHYLOXYETHYL) PHTHALATE for cosmetic use.
1,4‑DIMETHYLPENTYLAMINE (DMPA).
DIMETHYLPHTHALATE in sunscreens, personal insect repellents or body lotion preparations for human use except in preparations containing 0.5% or less of dimethylphthalate.
2,4‑DINITROPHENOL for human use.
DISPERSE YELLOW 3 for use in hair dyes.
DULCIN for therapeutic use.
ETHYLENE GLYCOL for use in toothpastes or mouthwashes except in preparations containing 0.25% or less of ethylene glycol.
EUPATORIUM CANNABINUM (Hemp Agrimony) for therapeutic use.
FARFUGIUM JAPONICUM for therapeutic use.
FORMALDEHYDE (excluding its derivatives):

       (a) in oral hygiene preparations containing more than 0.1% of free formaldehyde; or

       (b) in aerosol sprays for cosmetic use containing 0.005% or more of free formaldehyde; or

       (c) in nail hardener cosmetic preparations containing 5% or more of free formaldehyde; or

       (d) in all other cosmetic preparations containing 0.05% or more of free formaldehyde except in preparations containing 0.2% or less of free formaldehyde when labelled with the warning statement:

           CONTAINS FORMALDEHYDE.
GAMMA BUTYROLACTONE (excluding its derivatives) in non‑polymerised form in preparations for domestic and cosmetic use.
HELIOTROPIUM spp. for therapeutic use.
HYDROGEN PEROXIDE (excluding its salts and derivatives) in teeth whitening preparations containing more than 6% (20 volume) of hydrogen peroxide except in preparations manufactured for, and supplied solely by, registered dental practitioners as part of their dental practice.
ISOPROPYL NITRITE.
JUNIPERUS SABINE [savin(e)] for therapeutic use.
KAMBO.
LEAD COMPOUNDS:

       (a)